Recall due to particles in solution

Important information from the Federal Office for Safety in Health Care concerning the suspension of the marketing authorization and the recall of all batches of the veterinary medicinal product "Kexxtone 32.4 g continuous-release intraruminal device for cattle. Monensin"

Recall due to deviations from the specification in terms of appearance

The manufacturer Bioteck S.p.A. of the CE-marked medical device CHONDROGRID® informs that counterfeits of this product have been found in Turkey.

Recall due to nitrosamine contamination above the permitted daily dose

Up-to-date information from the 27.05.-30.05.2024 meeting on new approvals, extensions of indication, newly published EPAR's and recently started procedures.

Recall due to particles in solution

Recall due to possible lack of efficacy and unintentional ingestion in non-target species

After a review process lasting almost a year, the WHO decided on 14.05.2024 to include the European network of EU and EEA medicines authorities, of which the Federal Office for Safety in Health Care is an essential and active part, as a recognized "regional entity" in the list of WHO Listed Authorities (WLA) for human medicines and vaccines.

"Extreme White Lightening Cream" contained the declared glucocorticoid clobetasol propionate and is therefore to be classified as an illegal medicinal product.